SlateStone Wealth’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61K | Sell |
17,967
-1,162
| -6% | -$3.95K | 0.01% | 283 |
|
|
2025
Q1 | $77K | Buy |
19,129
+3,041
| +19% | +$12.2K | 0.01% | 278 |
|
|
2024
Q4 | $104K | Buy |
16,088
+1,193
| +8% | +$7.71K | 0.01% | 280 |
|
|
2024
Q3 | $83K | Buy |
14,895
+2,395
| +19% | +$13.3K | 0.01% | 284 |
|
|
2024
Q2 | $70K | Buy |
+12,500
| New | +$70K | 0.01% | 276 |
|